Topics
Medulloblastoma | Etiopathogenesis | MYC(N)-amplified Tumors
Home > Publications > Topics > Medulloblastoma > Etiopathogenesis > MYC(N)-amplified Tumors
*Schwalbe EC, Lindsey JC, Danilenko M, Hill RM, Crosier S, Ryan
SL, Williamson D, Castle J, Hicks D, Kool M, Milde T, Korshunov A,
Pfister SM, Bailey S, Clifford SC.
Molecular
and clinical heterogeneity within MYC-family amplified
medulloblastoma is associated with survival outcomes: A
multicenter cohort study.
Neuro
Oncol. 2024 Oct 8:noae178. doi:
10.1093/neuonc/noae178. PMID:
39377358. Observational study. ˍ
Kumar D, Kanchan R, Chaturvedi NK.
Targeting
protein synthesis pathways in
MYC-amplified medulloblastoma.
Discov
Oncol. 2025 Jan 8;16(1):23. doi:
10.1007/s12672-025-01761-7. PMID:
39779613. Review. ˍ